The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...

STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

Universal, stage-agnostic molecular profiling in NSCLC is increasingly necessary, as under-testing (including absent RNA fusion panels) can misdirect immunotherapy use in EGFR/ALK-altered disease.

TestSprite Inc., a platform that offers end-to-end software testing using fully autonomous artificial intelligence, today announced early access to its platform today. The company’s platform provides ...

Panel biomarker testing can unlock some of the mysteries of treating patients so that they experience fewer side effects, better quality of life, longer survival rates and potentially, lower costs. At ...

Diagnostic yields in rare disease have risen markedly with genomic testing, with many patients experiencing downstream clinical benefit through improved decision-making, prognosis clarification, and ...

Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm We identified a cohort of 1,201 ...